Human adipose tissue-derived mesenchymal stem cells inhibit melanoma growth ?n vitro and in vivo

Anticancer Research

Volumn 35, Issue 1, 2015, Pages 159-168

  Ahn, Jin Ok ^a   Coh, Ye Rin ^a   Lee, Hee Woo ^a   Shin, Il Seob ^b   Kang, Sung Keun ^b   Youn, Hwa Young ^a  

^a Seoul National University   (South Korea)

^b K STEMCELL Co Ltd   (South Korea)

Author keywords

Adipose tissue derived mesenchymal stem cells (ATMSCs); Cytotherapy; Growth inhibition; Melanoma

Indexed keywords

ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE DERIVED MESENCHYMAL STEM CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL VIABILITY ASSAY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MELANOMA CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; TUMOR GROWTH; TUMOR VOLUME; WESTERN BLOTTING; ABDOMINAL SUBCUTANEOUS FAT; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE; CYTOLOGY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE TECHNIQUES; FEMALE; HUMANS; MELANOMA; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM TRANSPLANTATION; SUBCUTANEOUS FAT, ABDOMINAL; TUMOR BURDEN;

EID: 84920465623     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Faiao-Flores F, Coelho P, Arruda-Neto J and Maria DA: Boron neutron capture therapy induces cell cycle arrest and DNA fragmentation in murine melanoma cells. Appl Radiat Isot 69: 1741-1744, 2011.
2. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013.
3. Lee B, Mukhi N and Liu D: Current management and novel agents for malignant melanoma. J Hematol Oncol 5: 3, 2012.
4. Olszanski AJ: Current and future roles of targeted therapy and immunotherapy in advanced melanoma. J Manag Care Pharm 20: 346-356, 2014.
5. Karimkhani C, Gonzalez R and Dellavalle RP: A Review of Novel Therapies for Melanoma. Am J Clin Dermatol 15: 323- 337, 2014.
6. Romanov YA, Svintsitskaya VA and Smirnov VN: Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21: 105-110, 2003.
7. Momin EN, Mohyeldin A, Zaidi HA, Vela G and Quinones- Hinojosa A: Mesenchymal stem cells: new approaches for the treatment of neurological diseases. Curr Stem Cell Res Ther 5: 326-344, 2010.
8. da Silva Meirelles L, Chagastelles PC and Nardi NB: Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213, 2006.
9. Orbay H, Tobita M and Mizuno H: Mesenchymal stem cells isolated from adipose and other tissues: basic biological properties and clinical applications. Stem Cells Int 2012: 461718, 2012.
10. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP and Hedrick MH: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228, 2001.
11. Kern S, Eichler H, Stoeve J, Kluter H and Bieback K: Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301, 2006.
12. Tang XJ, Lu JT, Tu HJ, Huang KM, Fu R, Cao G, Huang M, Cheng LH, Dai LJ and Zhang L: TRAIL-engineered Bone Marrow-derived Mesenchymal Stem Cells: TRAIL Expression and Cytotoxic Effects on C6 Glioma Cells. Anticancer Res 34: 729-734, 2014.
13. Wang J, Ma D, Li Y, Yang Y, Hu X, Zhang W and Fang Q: Targeted delivery of CYP2E1 recombinant adenovirus to malignant melanoma by bone marrow-derived mesenchymal stem cells as vehicles. Anticancer Drugs 25: 303-314, 2014.
14. Belmar-Lopez C, Mendoza G, Oberg D, Burnet J, Simon C, Cervello I, Iglesias M, Ramirez JC, Lopez-Larrubia P, Quintanilla M and Martin-Duque P: Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth. BMC Med 11: 139, 2013.
15. Chen Q, Cheng P, Song N, Yin T, He H, Yang L, Chen X and Wei Y: Antitumor activity of placenta-derived mesenchymal stem cells producing pigment epithelium-derived factor in a mouse melanoma model. Oncol Lett 4: 413-418, 2012.
16. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ and Andreeff M: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62: 3603-3608, 2002.
17. Elzaouk L, Moelling K and Pavlovic J: Anti-tumor activity of mesenchymal stem cells producing IL-12 in a mouse melanoma model. Exp Dermatol 15: 865-874, 2006.
18. Qiao L, Xu Z-l, Zhao T-j, Ye L-h and Zhang X-d: Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett 269: 67-77, 2008.
19. Hou L, Wang X, Zhou Y, Ma H, Wang Z, He J, Hu H, Guan W and Ma Y: Inhibitory effect and mechanism of mesenchymal stem cells on liver cancer cells. Tumour Biol 35: 1239-1250, 2014.
20. Yan XL, Fu CJ, Chen L, Qin JH, Zeng Q, Yuan HF, Nan X, Chen HX, Zhou JN, Lin YL, Zhang XM, Yu CZ, Yue W and Pei XT: Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Breast Cancer Res Treat 132: 153-164, 2012.
21. Xu WT, Bian ZY, Fan QM, Li G and Tang TT: Human mesenchymal stem cells (hMSCs) target osteosarcoma and promote its growth and pulmonary metastasis. Cancer Lett 281: 32-41, 2009.
22. Sun T, Sun BC, Ni CS, Zhao XL, Wang XH, Qie S, Zhang DF, Gu Q, Qi H and Zhao N: Pilot study on the interaction between B16 melanoma cell-line and bone-marrow derived mesenchymal stem cells. Cancer Lett 263: 35-43, 2008.
23. Choi EW, Shin IS, Lee HW, Park SY, Park JH, Nam MH, Kim JS, Woo SK, Yoon EJ, Kang SK, Ra JC, Youn HY and Hong SH: Transplantation of CTLA4Ig gene-transduced adipose tissuederived mesenchymal stem cells reduces inflammatory immune response and improves Th1/Th2 balance in experimental autoimmune thyroiditis. J Gene Med 13: 3-16, 2011.
24. Vaid M, Prasad R, Sun Q and Katiyar SK: Silymarin targets betacatenin signaling in blocking migration/invasion of human melanoma cells. PLoS One 6: e23000, 2011.
25. Dai L-J, Moniri MR, Zeng Z-R, Zhou JX, Rayat J and Warnock GL: Potential implications of mesenchymal stem cells in cancer therapy. Cancer Lett 305: 8-20, 2011.
26. Secchiero P, Zorzet S, Tripodo C, Corallini F, Melloni E, Caruso L, Bosco R, Ingrao S, Zavan B and Zauli G: Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-Hodgkin's lymphoma xenografts. PLoS One 5: e11140, 2010.
27. Ganta C, Chiyo D, Ayuzawa R, Rachakatla R, Pyle M, Andrews G, Weiss M, Tamura M and Troyer D: Rat Umbilical Cord Stem Cells Completely Abolish Rat Mammary Carcinomas with No Evidence of Metastasis or Recurrence 100 Days Post-Tumor Cell Inoculation. Cancer Res 69: 1815-1820, 2009.
28. Cousin B, Ravet E, Poglio S, De Toni F, Bertuzzi M, Lulka H, Touil I, Andre M, Grolleau JL, Peron JM, Chavoin JP, Bourin P, Penicaud L, Casteilla L, Buscail L and Cordelier P: Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS One 4: e6278, 2009.
29. Yang C, Lei D, Ouyang W, Ren J, Li H, Hu J and Huang S: Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitro. Biomed Res Int 2014: 109389, 2014.
30. Han Z, Tian Z, Lv G, Zhang L, Jiang G, Sun K, Wang C, Bu X, Li R, Shi Y, Wu M and Wei L: Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. J Cell Mol Med 15: 2343-2352, 2011.
31. Khakoo AY, Pati S, Anderson SA, Reid W, Elshal MF, Rovira, II, Nguyen AT, Malide D, Combs CA, Hall G, Zhang J, Raffeld M, Rogers TB, Stetler-Stevenson W, Frank JA, Reitz M and Finkel T: Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203: 1235-1247, 2006.
32. Golias CH, Charalabopoulos A and Charalabopoulos K: Cell proliferation and cell cycle control: a mini review. Int J Clin Pract 58: 1134-1141, 2004.
33. Gali-Muhtasib H and Bakkar N: Modulating cell cycle: current applications and prospects for future drug development. Curr Cancer Drug Targets 2: 309-336, 2002.
34. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326(Pt 1): 1-16, 1997.
35. Dasari VR, Velpula KK, Kaur K, Fassett D, Klopfenstein JD, Dinh DH, Gujrati M and Rao JS: Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PLoS One 5: e11813, 2010.
36. Herceg Z and Wang Z-Q: Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 477: 97-110, 2001.
37. Takahara K, Ii M, Inamoto T, Komura K, Ibuki N, Minami K, Uehara H, Hirano H, Nomi H, Kiyama S, Asahi M and Azuma H: Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis. Biochem Biophys Res Commun 446: 1102-1107, 2014.
38. Clarke MR, Imhoff FM and Baird SK: Mesenchymal stem cells inhibit breast cancer cell migration and invasion through secretion of tissue inhibitor of metalloproteinase-1 and -2. Mol Carcinog 2014.
39. Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren N, Jia HL, Shi J, Wu JC, Dai C, Dong QZ and Qin LX: Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci 101: 2546-2553, 2010.
40. Dasari VR, Kaur K, Velpula KK, Gujrati M, Fassett D, Klopfenstein JD, Dinh DH and Rao JS: Up-regulation of PTEN in glioma cells by cord blood mesenchymal stem cells inhibits migration via downregulation of the PI3K/Akt pathway. PLoS One 5: e10350, 2010.
41. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M and Lang FF: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65: 3307-3318, 2005.
42. Moniri MR, Sun XY, Rayat J, Dai D, Ao Z, He Z, Verchere CB, Dai LJ and Warnock GL: TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells. Cancer Gene Ther 19: 652-658, 2012.
43. Seo SH, Kim KS, Park SH, Suh YS, Kim SJ, Jeun SS and Sung YC: The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity. Gene Ther 18: 488-495, 2011.